It becomes tricky when money in the bank becomes low. by that i mean less than 4 quarters.
Have a look at how this money is to be spent, and compare that amount to money in the bsnk prior to CR.
Without the money the pipeline wont be progressed. Without the pipeline progressing, shareholder value wont grow. The joy of drug discovery biotechs.
That pipeline looks pretty bloody good. It needs to be kept funded and kept moving.
Ann: Entitlement Offer to raise approximately $18.1 million, page-7
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
